HR p.value 2.5 % 97.5 %
age diag 1.050267 0.02331534 1.008018 1.094287
sex 0.8049478 0.6923408 0.249373 2.598281
classes ttt 0.5438592
-classe 2 1.031283 0.09910023 10.732010
-classe 3 0.523994 0.04376179 6.274189
type atteinte 0.684302 0.5587586 0.1671439 2.801594
diabete 3.189321 0.07508205 0.8710499 11.6776
hta 9.320657 0.01346051 1.745986 49.75678
IMC 0.962062 0.7128323 0.7500813 1.233951
### Survival by treatement
group
HR p.value 2.5 % 97.5 %
age diag 1.0487276 0.05443958 0.99871175 1.101248
sex 0.6790250 0.55174795 0.14449440 3.190954
classes ttt 0.8009221
-classes 2 0.6649864 0.02200625 20.094601
-classes 3 0.4698116 0.01510594 14.611663
diabete 2.2152131 0.36267873 0.28245219 17.373450
type atteinte 0.7492038 0.72919216 0.08819381 6.364465
IMC 0.8990143 0.44970094 0.60282363 1.340735
Number of participants: 101
Mean survival: 991.4 (±290)
Median survival: 1096 [1095 ; 1096]
Number of events: 14